Capitala Group Leads $27.3 Million Investment in Optio RX, LLC

July 23, 2018

Capitala Group (“Capitala”), a provider of capital to lower and traditional middle market companies, announced today that it recently originated a combination of a senior secured debt facility and minority equity totaling $27.3 million to support Cold Bore Capital in the formation of Optio RX, LLC (“Optio”).

Based out of Nashville, TN, Optio is an owner and operator of specialty compounding pharmacies and home infusion providers licensed across the United States. Optio currently specializes in providing medication and care in the fertility, veterinary and hemophilia segments. Capitala’s investment will help fund the company’s next phase of growth as it looks to acquire additional specialty pharmacies across the country.

About Capitala Group
Capitala Group is a $2.7 billion asset management firm that provides capital to lower and traditional middle market businesses throughout North America with office locations in Atlanta, Charlotte, Fort Lauderdale, Los Angeles, New York, and Raleigh. Capitala’s lower middle market investment strategy focuses on investing in debt securities with minority equity co-investments with less than $250 million in enterprise value through its permanent capital vehicles, Capitala Finance Corp. (Nasdaq:CPTA) and Capitala Specialty Lending Corp. (CSLC). Capitala’s growth fund strategy targets control and minority equity investments, typically coupled with credit investments, in lower middle market companies with less than $30 million in enterprise value through both SBIC (CapitalSouth SBIC Fund IV, L.P.) and non-SBIC closed-end funds. Capitala Group has invested in over 150 companies since its inception in 1998 and seeks to partner with strong management teams to create value and achieve optimal outcomes for its investors.For more information, visit our website at